Juana Oramas

University Hospital Of The Canary Islands
Santa Cruz De Tenerife, CN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Durvalumab plus platinum-etoposide in the first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): A single-arm clinical trial.

Durvalumab plus platinum-etoposide in the first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): A single-arm clinical trial.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: July 07, 2025

Incidence of second primary cancers in lung cancer survivors by oncological treatment: a nationwide prospective cohort study in Spain.

Incidence of second primary cancers in lung cancer survivors by oncological treatment: a nationwide prospective cohort study in Spain.

Journal: The Lancet regional health. Europe

Published: April 10, 2025

Challenges and perspectives in the management of BRAF-mutated metastatic melanoma: Systemic treatment sequencing and brain metastases.

Challenges and perspectives in the management of BRAF-mutated metastatic melanoma: Systemic treatment sequencing and brain metastases.

Journal: Cancer treatment reviews

Published: November 06, 2024

Multi-omics Characterization of Response to PD-1 Inhibitors in Advanced Melanoma.

Multi-omics Characterization of Response to PD-1 Inhibitors in Advanced Melanoma.

Journal: Cancers

Published: July 25, 2023

Sorting Transcriptomics Immune Information from Tumor Molecular Features Allows Prediction of Response to Anti-PD1 Therapy in Patients with Advanced Melanoma.

Sorting Transcriptomics Immune Information from Tumor Molecular Features Allows Prediction of Response to Anti-PD1 Therapy in Patients with Advanced Melanoma.

Journal: International journal of molecular sciences

Published: November 07, 2022

Molecular Divergence upon EGFR-TKI Resistance Could Be Dependent on the Exon Location of the Original EGFR-Sensitizing Mutation.

Molecular Divergence upon EGFR-TKI Resistance Could Be Dependent on the Exon Location of the Original EGFR-Sensitizing Mutation.

Journal: Cancers

Published: August 19, 2022

Determination of essential biomarkers in lung cancer: a real-world data study in Spain with demographic, clinical, epidemiological and pathological characteristics.

Determination of essential biomarkers in lung cancer: a real-world data study in Spain with demographic, clinical, epidemiological and pathological characteristics.

Journal: BMC cancer

Published: January 19, 2022

Are there differences by sex in lung cancer characteristics at diagnosis? -a nationwide study.

Are there differences by sex in lung cancer characteristics at diagnosis? -a nationwide study.

Journal: Translational lung cancer research

Published: July 09, 2021

Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice.

Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice.

Journal: OncoTargets and therapy

Published: June 17, 2021

Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using real-life data.

Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using real-life data.

Journal: BMC cancer

Published: April 14, 2021

Prospective Exploratory Analysis of Angiogenic Biomarkers in Peripheral Blood in Advanced NSCLC Patients Treated With Bevacizumab Plus Chemotherapy: The ANGIOMET Study.

Prospective Exploratory Analysis of Angiogenic Biomarkers in Peripheral Blood in Advanced NSCLC Patients Treated With Bevacizumab Plus Chemotherapy: The ANGIOMET Study.

Journal: Frontiers in oncology

Published: April 14, 2021

Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial.

Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial.

Journal: Nature communications

Published: March 26, 2021

Showing 1-12 of 21

Last Updated: 09/26/2026